University of Tsukuba · Faculty of Medicine · 准教授

Research keywordsurothelial carcinoma・enfortumab vedotin・neoadjuvant chemotherapy・urologic oncology・treatment stratification・geriatric nutritional risk・metastatic disease・dermatologic toxicity

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Prognostic impact of neoadjuvant chemotherapy for muscle-invasive bladder cancer in patients with low geriatric nutritional risk index: A retrospective cohort study2026 · 論文
• Outcomes and Management of Dermatologic Toxicity Following Enfortumab Vedotin Rechallenge in Patients With Metastatic Urothelial Carcinoma: A Retrospective Single-Center Study2026 · 論文
• Impact of European Association of Urology Combination and Platinum Eligibility on Real-World Treatment Sequences and Survival in Japanese Patients With Metastatic Urothelial Carcinoma2026 · 論文
• Diagnostic uncertainty of clinical T2 disease and its impact on treatment stratification in upper tract urothelial carcinoma: a multicenter retrospective study2026 · 論文

• 膀胱がん微小環境におけるPLD1/2によるイムノメタボリズムの制御機構の解明2022 · 日本学術振興会/基盤研究(C)
• 脂肪酸伸長酵素ELOVLによる脂質の質的変容を介した腎癌の進展メカニズムの解明2019 · 日本学術振興会/基盤研究(C)
• 腎癌の脂肪酸伸長酵素ELOVL2による脂質の質的変容を介した悪性化機序の解明2017 · 日本学術振興会/若手研究(B)

• Official profile